A Meta-Analysis of Non-stimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED by Daniel F. Connor, R. Thomas Boone, Ronald.

Slides:



Advertisements
Similar presentations
Improving Teen Mental Health
Advertisements

Pharmacologic Treatments. 2 Cognitive Behavioural Therapy (CBT) Psychosocial Interventions.
1. Diagnostic and Statistical Manual of Mental Disorder (DSM) International Classification of Diseases (ICD) 2.
Marlene B. Huff PhD, LCSW University of Kentucky Department of Pediatrics Division of Adolescent Medicine.
Infant, Childhood, and Adolescent Disorders SW 593 Assessment & Diagnosis.
The Effect of Comorbidity on Treatment Outcome in an ODD Sample European Association for Behavioral and Cognitive Therapies, Reykjavik, Iceland, September.
+ Evidence Based Psychosocial Treatments for Children and Adolescents: A Ten Year Update Training School Psychologists to be Experts in Evidence Based.
+ Evidence Based Practice University of Utah Presented by Will Backner December 2009 Training School Psychologists to be Experts in Evidence Based Practices.
Evidence-Based Psychosocial Treatment of Disruptive Behavior Disorder - Overview Developed by the Center for School Mental Health with support provided.
Overview of Mental Health Medications for Children and Adolescents Module 5 ADHD and Disruptive Behavior Disorders 1.
Understanding a person’s challenging behaviour A psychiatric perspective Tony Holland University of Cambridge.
Mood Disorders. Level of analysis Depression as a symptom Depression as a syndrome Depression as a disorder.
FASD: Co morbid psychiatric conditions and psychopharmacology Dr. Terri Erwin Assistant Professor of Psychiatry Division of Child and Adolescent Psychiatry.
“This multimedia product and its contents are protected under copyright law. The following are prohibited by law: any public performance or display, including.
Emotional and Behavioral Disorders ESE 380 February 19, 2009.
Arifah Nur Istiqomah Departemen/SMF Ilmu Kedokteran Jiwa FK Unpad/RSHS.
Depressive Disorders.
Attention ‑ Deficit/ Hyperactivity Disorder (ADHD; Chapter 15)
Oppositional Defiant Disorder Andrea, Janet, Liz and Sonia.
CHILD PSYCHIATRY Fatima Al-Haidar Professor, child & adolescent psychiatrist College of medicine - KSU.
Oppositional Defiant Disorder (ODD) Age-inappropriate, stubborn, hostile, and defiant behavior, including:  losing temper  arguing with adults  active.
The Evidence Base for Psychosocial and Psychopharmacological Interventions for Children with Attention-Deficit/Hyperactivity Disorder, Major Depressive.
Youth Empowerment Services (YES) A Medicaid Waiver Program for Children with Severe Emotional Disturbances Clinical Eligibility Determination Texas Department.
Diana Browning Wright, Behavior/Discipline Trainings, 2002 ODD/CD IMPLICATIONS? ODD/CD in evidence? Not responding to behavioral interventions alone? 60%
Disorders of Childhood and Adolescence. Externalizing Disorders  Disorders with behaviors that are disruptive and often aggressive  Attention-deficit.
Mental Health Nursing II NURS 2310 Unit 11 Psychiatric Conditions Affecting Children and Adolescents.
ADHD and Psychopharmacology By Monica Robles M.D.
Continuity Clinic Depression. Continuity Clinic Objectives.
Chapter 6 Emotional and Behavioral Disorders
Disorders of Childhood A General Overview Dr. Bruce Michael Cappo Clinical Associates, P.A.
Psychopharmacology – A brief introduction. Objectives Review general categories of psychiatric disorders Review general categories of psychiatric disorders.
ADHD& CO-morbidities Dr. Fatima Al-Haidar Professor & Consultant Child and Adolescent Psychiatrist.
Behavioral and Emotional Correlates of ADHD in Children Tammy D. Barry, Ph.D. 1, Christopher T. Barry, Ph.D. 1, Beth H. Garland, M.A. 2, and Robert D.
Attention Deficit Disorder December 8, Attention Deficit Hyperactivity Disorder: DSM-IV-TR ADHD: combined type ADHD: combined type ADHD: predominantly.
Is ADHD overdiagnosed? 1.Where do you stand on the diagnosis of ADHD – do you think it is overdiagnosed? Why or why not? 2.What factors might lead to overdiagnosis.
Incidence of Autism Spectrum Disorders Jean A. Frazier, MD Executive Director, Eunice Kennedy Shriver Center Robert M. and Shirley S. Siff Chair in Autism.
Ryoichi J. P. Noguchi, M.S., Michael M. Knepp, M.S., & Thomas H. Ollendick, Ph.D. INTRODUCTION METHOD  Studies of attention and memory have consistently.
PSYCHIATRIC DISORDERS IN CHILDHOOD AND ADOLESCENCE Robert L. Hendren, D.O. Professor of Psychiatry and Pediatrics UMDNJ-RWJMS.
Alan Breier, M.D. Leader, Zyprexa Product Team Lilly Research Fellow Professor of Psychiatry, Indiana University School of Medicine Adjunct Associate of.
Announcements 1. Clinical treatment writing assignment Choose a topic—some child problem (e.g. sleep problem, ADHD, autism, etc.) Choose a topic—some child.
Adolescent Mental Health Depression Signs. Symptoms. Consequences.
CONDUCT DISORDER By: Takiyah King. Background The IQ debate The IQ debate Impulse control Impulse control Response Inhibition Response Inhibition.
CHAPTER 14 DISORDERS OF CHILDHOOD AND ADOLESCENCE.
 New classification/grouping category for conduct disorder, etc. © 2014 S. Dziegielewski.
Dr TG Magagula 13 August Behavioral disorder: noise-making, motor driven.
Students with Emotional and Behavioral Disorders ESE 380Fall 2009.
Treatment Resistant Pediatric BD Elham Shirazi M.D. Board of General Psychiatry Board of Child & Adolescent Psychiatry.
Disruptive Behavioral Disorders Fatima AlHaidar Professor, Child & Adolescent Psychiatrist KSU.
Referral Rates for Intervention or Assessment: A Meta-Analysis of Racial Differences by John Hosp & Daniel Reschly Presented by Breann Herring Radford.
Beginning in late infancy, all children display aggression from time to time.
ADHD –Comorbidity Issues Regina Bussing, M.D., M.S.H.S. Chief, Division of Child and Adolescent Psychiatry.
Developmental Considerations Most Common Adjustment Problems –Attachment problems or developmental delays in.
WEEK 3 CLASSIFICATION AND ASSESSMENT OF ABNORMAL PSYCHOLOGY.
Chapter 10 Conduct Disorder and Related Conditions.
Conduct Disorder By: Shannon Frederick and Scott Winterbottom and Ken Carson and.
“Focusing on the Process” Jeff Schmidt MD.  Recommendation #1: Children ages 4-18 who present with academic underachievement, behavior problems or.
Chapter 10 Childhood Disorders. Copyright © 2011 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 10 2.
Chapter 6: Teaching Students with Emotional and Behavioral Disorders Angel Galvez ED /28/13.
Title, Edition ISBN © 2009 Pearson Education, Inc. All rights reserved. Exceptional Children: An Introduction to Special Education, 9th Edition ISBN X.
Introduction Risperidone, known by the brand name of Risperdal, is an atypical antipsychotic medication often prescribed to adolescents in psychiatric.
Anxiety & Mood Disorders In Children. Anxiety Disorders Common among children – 9.7% in a community-based school sample More girls than boys Fears are.
Children and Adolescents Chapter 23. ½ of all Americans will meet criteria for DSM-IV disorder 1 in 5 children and adolescents suffer from major psychiatric.
Outline – Lecture 5, Feb. 4/03 Ch. 5: ADHD
Disorders in Childhood and Adolescence
Disorders of Childhood and Adolescence
Disruptive, Impulse-Control and Conduct Disorders
Chapter 22 Attention Deficits and Hyperactivity
Conduct Disorder & Oppositional Defiant Disorder
Chapter 29 Behavioral and Psychiatric Disorders in Children with Disabilities Overview Developmental disabilities and prevalence of psychiatric disorders.
Disruptive Mood Dysregulation Disorder (DMDD)
Presentation transcript:

A Meta-Analysis of Non-stimulant Medication Effects on Overt Aggression-Related Behaviors in Youth with SED by Daniel F. Connor, R. Thomas Boone, Ronald J. Steingard, Ivan D. Lopez, & Richard H. Melloni, Jr. Presented by: Tzu Min Lee Radford University

Purpose To determine the effect size for non-stimulant medications on symptoms of overt aggression- related behaviors in referred children and adolescents with serious emotional and behavioral disturbances. - Prevalence of pharmacological interventions - Overall efficacy of medications to treat aggression unclear - A literature review back to 1955 revealed no other meta-analysis except one in 2002 to assess the effects of stimulant medications on overt and covert aggression in youth with ADHD

Issues to Consider How is medications determined? - used to treat aggression-related behaviors in youth with developmental delay, ADHD, CD, depression, schizophrenia, anxiety disorders, bipolar disorder and tic disorders How is aggression-related behaviors defined? - why overt aggression - defined broadly to be consistent with the multiplicity of aggression problems faced by clinicians in practice

Literature Review medical & behavioral science Methods - Electronic Sources * Medline * PsycInfo * Pub Med - Journal bibliographies Studies - 41 were found - 33 met the inclusion/exclusion criteria

Studies to Include Report quantitative data on independent drug effects (neuroleptics, atypical antipsychotics, mood stabilizers, antidepressants and adrenergic agents) Published in peer-reviewed scientific journal Use a placebo control either in cross-over or parallel-group methodological design Have a mean sample age of 19 years or younger Use a valid rating scale or method of observation to assess aggression-related behaviors Open studies, case reports and review articles are excluded.

Dependent Measures Overt aggression-related behaviors - physical assault, verbal threats, oppositional and defiant behavior, noncompliance, rule defiance, malicious teasing of others, conduct problems, disruptive behavior, poor self-control, explosive outbursts of property destruction, temper tantrums, hyperactivity/impulsivity, explosive rage attacks, hostility, and/or irritability

Dependent Measures Clinician Rating - Brief Psychotic Rating Scale (BPRS) - Children’s Psychiatric Rating Scale (ChPRS) - Rating Scale of Abnormal Behavior Checklist (RSABC) Parent Rating - Conners Parent/Teacher Rating Scale (CPRS & CPRS) Teacher Rating - Teachers Self-Control rating Scale (TSCRS) Overall Rating - Average of effects for all reporters in each given study

Results * p <.0001 for all ratings EFFECTS OF DRUGS ON OVERT AGGRESSIVE BEHAVIOR 95% CIFile- drawer X Criteria N d L U Clinician Rating Parent Rating Teacher Rating Overall Rating

Potential Moderators Mean sample age Percentage of boys in the sample Drug group - neuroleptics, atypical antipsychotics and mood stabilizers - antidepressants and adrenergic agents Study design - within-subjects - between-subjects Interaction between drug type & study design

Results – Moderators Drug Group, Study Design and their Interaction DRUG GROUP STUDY DESIGN Within-subjectsBetween-subjects Antipsychotic Antidepressant

Study Limitations Limitations of the extant published literature - small sample sizes, absence of drug use means and standard deviations Grouping medications to increase statistical power diminished the precision of analysis Risk of inflating Type 1 error by combining diverse ratings within an individual study into a single rating Haloing effects of medication improvements on core features of psychiatric disorders

Clinical Implications Results support the continued use of medication therapy as part of a multimodal treatment plan. Parent ratings of their children did not entirely endorse medication interventions as always effective Benefits of medical interventions must be balanced with their potential risks. Need for a thorough, multidisciplinary psycho- educational evaluation since overt aggression is heterogeneous in etiology. Treatment plans must consider diverse psychosocial family, individual, community, educational, and psychopharmacological treatment interventions.

Future Research A need for continued, comprehensive research Define aggressive behavior explicitly Examine drug effects on certain types of aggression - physical assault, reactive aggression, proactive aggression, covert aggression, CD/ODD Investigate social validity measures - effects of drugs on quality-of-life measures for child and family